{"name":"Catherine Vandepitte, M.D.","slug":"catherine-vandepitte-m-d","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Liposome bupivacaine","genericName":"Liposome bupivacaine","slug":"liposome-bupivacaine","indication":"Infiltration anesthesia for surgical procedures","status":"marketed"}]}],"pipeline":[{"name":"Liposome bupivacaine","genericName":"Liposome bupivacaine","slug":"liposome-bupivacaine","phase":"marketed","mechanism":"Liposome bupivacaine is a long-acting local anesthetic that uses liposomal encapsulation to extend the duration of bupivacaine's nerve-blocking effects.","indications":["Infiltration anesthesia for surgical procedures","Interscalene brachial plexus block for shoulder surgery","Transversus abdominis plane (TAP) block for abdominal surgery","Postoperative analgesia"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}